Rebecca Paul
Rebecca Paul is a prominent figure in the intersection of computational biology and pharmaceutical science, serving as the Head of Medicinal Drug Design at isomorphic-labs.
Professional Role
- Position: Head of Medicinal Drug Design at isomorphic-labs.
- Organization: isomorphic-labs is a spin-off from google-deepmind, focusing on applying artificial intelligence to accelerate drug discovery.
- Key Focus: Leveraging AI-driven approaches to revolutionize the design and discovery of new medicines.
Key Contributions & Insights
- Featured in discussions regarding the application of AI in medicinal chemistry, specifically alongside Max Jaderberg (Chief AI Officer).
- Explores the integration of advanced AI models, such as those derived from AlphaFold, into the drug design pipeline.
- Discusses the shift from traditional methods to AI-augmented workflows for identifying potential cures.